Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: cm who wrote (859)	7/29/1999 12:58:00 PM
From: BRAVEHEART	Read Replies (2) \| Respond to of 1386

Hi Gang, Carl Icon is a mixed blessing. He likes to control things. He is a prudent man who believes in efficiency. Another biotech firm ( the name eludes me ) he was involved with was essentially prevented from any unnecessary spending & acquisitions that wouldn't improve the bottom line. Biotech could use much more of this applied to their overall strategy. Too many companies waste limited funds on R&D that will never fly. Given PARS current status of becomming profitable ICON should be a good thing if this rumor is true. He should be able to maximize the value. Personally I would reverse this stock...say a 2 for one ...Reduce the float and put it in the hands of instutions. Just an opinion... Jeffrey